4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000106
Director sold 200 shares at $40.00 ($8,000)
- Director acquired 200 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Scadden David · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-30 | Exercise or conversion : show line 1 in the form 10b5-1 | +200 | $18.09 | $3,618 | 17,803 | D |
| 2025-09-30 | Sale : show line 2 in the form 10b5-1 | −200 | $40.00 | $8,000 | 17,603 | D |
| Open-market sales · 200 sh · avg $40.00 · $8,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-30 | Exercise or conversion : show line 3 in the form 10b5-1 Stock options (right to buy) | −200 | 27,307 | D |
Loading xslF345X05/wk-form4_1759435431.xml…